Dr. Bryan John Marsh, MD

Dr. Marsh practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Marsh's NPI, 1417974304, was assigned on July 16, 2006. Dr. Marsh graduated from Pritzker School of Medicine in 1990. Dr. Marsh holds New Hampshire license 8898.

Dr. Marsh's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Marsh's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Marsh is also affiliated with Alice Peck Day Memorial Hospital. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Marsh to 3 more hospitals and 1 medical group, each named with a free account. Dr. Marsh's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marsh practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Marsh's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Marsh is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Marsh's licenses on file in 3 states: New Hampshire, Vermont and Maine.

Dmand AI lists hiv/aids, joint or bone infection and pneumonia among the conditions Dr. Marsh treats.

CMS data shows 236 Medicare services from Dr. Marsh across 5 procedure codes in 2024, for 178 Medicare patients. Medicare paid $18,801 for them.

CMS counts 178 Medicare patients who saw Dr. Marsh in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marsh's median patient age at 56, with 37% women.

In 2024, Dr. Marsh wrote 1,944 Medicare Part D claims for 261 patients. CMS names the drug for 1,657 of them, across 45 drugs with 11 or more claims each, at $3,232,381 in total drug cost. In 2023, CMS named 1,633 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Marsh for performance year 2024, reported through an alternative payment model (APM). Dr. Marsh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marsh as offering telehealth.

Dmand AI links 22 papers to Dr. Marsh, published from 2003 to 2010. The most frequent topics are Mycobacterium tuberculosis, HIV Infections and Antigens. Dr. Marsh has published most often in Clin Infect Dis. Dr. Marsh's most frequent co-authors are Max Roe O'Donnell, MD, Charles R. Horsburgh, MD and John Frederic Modlin, MD.

CMS Open Payments shows 17 general payments to Dr. Marsh from 2 drug and device companies from 2016 to 2018. Consulting fees make up the largest share, 60% of the total. Gilead Sciences, Inc. paid the most, $6,209.

Dmand AI lists 1 award for Dr. Marsh, most recently CMS Stage 1 EHR in 2013.

Dr. Marsh graduated from Pritzker School of Medicine in 1990.

Dr. Marsh is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.